Rising Pharma Holding, Inc. recalls
3 recalls filed under Rising Pharma Holding, Inc.. The most recent was published July 29, 2026.
-
Class II · 3 months ago
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL recall: Presence of Precipitate: medication was crystallizing and particles floating
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
-
Class II · 8 months ago
Rising Pharma Holding, Inc. Product label: Temozolomide Capsules, 5mg recall: Failed Impurities/Degradation Specifications: An out-of-specification result
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
-
Class II · 1+ years ago
Rising Pharma Holding, Inc. Carbidopa, Levodopa, Entacapone Tablets recall: Product mix up: complaint received that sealed medication bottle contained
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150…
About this page
Rising Pharma Holding, Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.